Clinical trial
Enalapril in Treating Heart Damage Patients Who Received Anthracycline…
NCT00003070 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003070 |
|---|---|
| Title | Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer |
| Official title | Afterload Reduction Therapy for Late Anthracycline Cardiotoxicity: A Pediatric Oncology Group Cancer Control Study |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiac Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Drug, Procedure |
| Interventions | enalapril maleate, quality-of-life assessment |
| Enrollment | 13 |
| Start date | Sep 1, 2000 |
| Primary completion | Jul 1, 2003 |
| Completion | Mar 1, 2007 |
| First posted | Mar 1, 2004 |
| Last update posted | Aug 5, 2014 |
| Countries | Canada, Switzerland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: